GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Monday, 22nd Apr 2024 ABUS stock ended at $2.64. This is 2.94% less than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 3.98% from a day low at $2.64 to a day high of $2.74.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Feb 12, 2021 $4.38 $4.41 $4.24 $4.33 1 777 428
Feb 11, 2021 $4.41 $4.61 $4.15 $4.38 2 648 153
Feb 10, 2021 $4.55 $4.73 $4.27 $4.43 3 340 524
Feb 09, 2021 $5.00 $5.14 $4.45 $4.47 6 907 862
Feb 08, 2021 $4.29 $4.89 $4.23 $4.84 11 406 284
Feb 05, 2021 $4.24 $4.24 $3.99 $4.15 4 191 856
Feb 04, 2021 $3.91 $4.26 $3.86 $4.16 5 354 797
Feb 03, 2021 $3.96 $4.02 $3.86 $3.90 1 898 361
Feb 02, 2021 $3.97 $4.00 $3.87 $3.92 1 803 354
Feb 01, 2021 $3.91 $4.03 $3.84 $3.88 3 825 943
Jan 29, 2021 $3.86 $3.93 $3.63 $3.78 2 477 420
Jan 28, 2021 $3.75 $3.78 $3.61 $3.67 2 319 427
Jan 27, 2021 $3.74 $4.08 $3.58 $3.74 4 060 169
Jan 26, 2021 $3.99 $4.02 $3.77 $3.82 3 058 305
Jan 25, 2021 $4.03 $4.08 $3.84 $4.01 2 577 150
Jan 22, 2021 $3.97 $4.12 $3.91 $4.05 1 657 047
Jan 21, 2021 $4.11 $4.14 $3.91 $3.96 1 916 021
Jan 20, 2021 $4.20 $4.28 $3.99 $4.11 2 331 085
Jan 19, 2021 $3.95 $4.19 $3.78 $4.07 2 617 728
Jan 15, 2021 $4.04 $4.11 $3.90 $3.91 2 342 520
Jan 14, 2021 $4.10 $4.13 $3.96 $4.03 2 038 657
Jan 13, 2021 $4.12 $4.13 $3.93 $4.04 2 214 075
Jan 12, 2021 $4.21 $4.23 $3.97 $4.10 3 367 386
Jan 11, 2021 $3.91 $4.49 $3.90 $4.32 5 795 928
Jan 08, 2021 $4.04 $4.16 $3.81 $3.87 3 266 687
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT